{"id":"897994636209-21","name":"PHARMABIOTIC RESEARCH INSTITUTE","registrationDate":"2019-10-14T13:18:06.273+02:00","category":3,"subCategory":2,"legal":"ASSOCIATION","web":"http://pharmabiotic.org","country":"France","headAddress":"1 quai Valliere","headCity":"Narbonne","headPostCode":"11100","headPhone":"(33)09 81 00 62 48","boss":"BRUNO POT","bossTitle":"Mr","bossPosition":"PRESIDENT","membersCount":2,"membersFTE":"2.0","membership":"no membership in any other organization","memberOrga":"https://www.pharmabiotic.org/ourmembers/","goal":"The PRI is a non profit organization supporting its academic and industry members in their effort to develop microbiome-based medicinal products. &#xd;<br />The PRI supports its members in their interaction with the competent authorities (EMA and national) in order to better understand the expectations of the drug authorities in regards to microbiome-based products in absence of European regulatory framework.&#xd;<br />The PRi is also the first network for the European microbiome pharmaceutical supply chain, federating fundamental actors from the industry, such as stakeholders involved in the development, investment, production and commercialization within the EU.","acronym":"PRI","interests":"Public Health, Research and innovation","euInitiatives":"The PRI is an expert at the European Pharmacopoe√Øa and participated in the discussions of the task group working on a new monograph for LBPs released in March 2019.&#xd;<br />&#xd;<br />the PRI also interacted through e-mails with the CAMD and the national competent authorities for medical devices in regards to the transitional provisions of the new regulation and the fate of products containing living microorganisms and already on the market on 25 of May 2020.","lastUp":"2019-10-14T14:35:18.130+02:00","customers":"","costAbsolu":"","costRange":"","turnoverAbsolu":0,"turnoverRange":""}